Phase II Conjugation Reactions: Overview
Antibody Actions
Antibody Structure
Hybridoma Technology
Conjugated Proteins
Site-Targeted Drug Delivery Systems: Polymeric Carriers
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Alain Beck1, Janice M Reichert2
1Centre d'Immunologie Pierre Fabre; Saint-Julien-en-Genevois, France.
Antibody-drug conjugates (ADCs) represent a growing class of therapeutics. Recent FDA and EMA approvals for brentuximab vedotin and ado-trastuzumab emtansine highlight their therapeutic potential in cancer treatment.
Area of Science:
Background:
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
09:39Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
Published on: September 17, 2019